Table 2.
Tumoral characteristic | Number (%) |
---|---|
Primary tumor | |
Largest size | |
Mean ± SEM | 5.8 ±0.5 |
[range] | [2-13] |
Number | |
Mean ± SEM | 1.5 ± 0.2(a) |
[range] | [1-5] |
Preoperative primary location | |
Pancreatic head/duodenum | 27 (59%)(b) |
Pancreatic body | 9 (20%) |
Pancreatic tail | 8 (17%) |
Other | 2 (4%) |
Metastases present | 35 (76%) |
Lymph node metastases present | 27 (59%) |
Liver metastases (limited) | 14 (30%)(c) |
Vessels involved/abuts | 46(100%) |
Portal vein or tributary | 20 (43%) |
SMV/SMA | 16 (35%) |
IVC | 4 (9%) |
Splenic vein | 4 (9%) |
Heart | 2 (4%) |
Six patients with gastrinomas with MEN1 had multiple primary PETs Identified preoperatively.
Imaging studies could not clearly differentiate whether in pancreatic head or duodenum.
Limited liver metastases refer to patients without diffuse liver metastases and liver metastatic disease thought completely resectable.
Abbreviations; SMV/SMA-superior mesenteric artery/vein; IVC-inferior vena cava;